S
5.31
-0.62 (-10.39%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Sana Biotechnology, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
-0.2
| 分析师共识 | -1.5 |
| 内部交易活动 | 1.5 |
| 价格波动 | -5.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 4.0 |
| 平均 | -0.20 |
|
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 8.46% |
| 机构持股比例 | 89.37% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Flagship Pioneering Inc. | 30 Jun 2025 | 25,001,856 |
| Canada Pension Plan Investment Board | 30 Jun 2025 | 10,175,000 |
| Crestline Management, Lp | 30 Jun 2025 | 2,420,937 |
| Integral Health Asset Management, Llc | 30 Jun 2025 | 1,500,000 |
| 52周波幅 | ||
| 中 | 5.00 (-5.75%) | |
| 总计 | 1 购买 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Wedbush | 24 Sep 2025 | 5.00 (-5.75%) | 购买 | 3.41 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| BISHOP HANS EDGAR | 4.16 | - | 5,628 | 23,412 |
| 累积净数量 | 5,628 | |||
| 累积净值 ($) | 23,412 | |||
| 累积平均购买 ($) | 4.16 | |||
| 累积平均卖出 ($) | - | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| BISHOP HANS EDGAR | 董事 | 06 Oct 2025 | 获得 (+) | 5,628 | 4.16 | 23,412 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合